ORIOLA Oriola Oyj
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.…
Industry Peers
Pharmaceutical RetailersKey Statistics
About Oriola (HEL: ORIOLA)
›
Oriola (HEL: ORIOLA) is listed on Nasdaq Helsinki, where its shares trade in EUR. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 800 employees.
The shares were at 0.7480 EUR on 19 November 2026, down 31.7% over 52 weeks. Its 52-week range is 0.7260 EUR to 1.260 EUR: the price is 40.6% below the high and 3.0% above the low.
Its market capitalisation is 137.82M EUR. It pays a dividend yielding 3.94% (it pays out 200% of its earnings), against a median of 3.45% among the dividend payers in that peer group.
Oriola reports return on equity of -27.0%, an operating margin of 0.1% and revenue up 5.2% year over year.
It holds more cash than debt, a net cash position of 37.50M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Hold; their mean price target of 0.8675 EUR is 16.0% above the current price. The next earnings report is expected on 23 February 2027.